✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Shanghai RAAS Blood Products Co Ltd

Common Name
Shanghai RAAS Blood Products
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
4,045
Ticker
002252
Exchange
SHENZHEN STOCK EXCHANGE
Description
Shanghai RAAS Blood Products Co., Ltd. is a leading biotechnology company specializing in the production and distribution of blood plasma-derived products. Operating within the pharmaceutical sector, ...

Disclosures of Shanghai RAAS Blood Products

Explore Shanghai RAAS Blood Products's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Shanghai RAAS Blood Products's official channels and fully traceable to its official company sources.

The table below lists all of Shanghai RAAS Blood Products's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

Fiscal Year / TypeLanguages
20251 disclosure
Sustainability Report
zh
20242 disclosures
Sustainability Report
zh
Annual Report
zh
20232 disclosures
Annual Report
zh
Responsibility Report
zh
20222 disclosures
Annual Report
zh
Responsibility Report
zh
20212 disclosures
Responsibility Report
zh
Annual Report
zh
20202 disclosures
Annual Report
zh
Responsibility Report
zh
20192 disclosures
Annual Report
zh
Responsibility Report
zh
20182 disclosures
Annual Report
Responsibility Report
zh
20172 disclosures
Annual Report
zh
Responsibility Report
zh
20162 disclosures
Responsibility Report
zh
Annual Report
zh
20152 disclosures
Webpage captured from company’s website
Annual Report
zh
20141 disclosure
Webpage captured from company’s website
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?